$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
The Near-Perfect Portfolio: Sleep Well During Turbulent Times
02:00pm, Saturday, 11'th Mar 2023 Seeking Alpha
With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. Read more here.
3 No-Brainer Dividend Stocks to Buy in March
11:14am, Saturday, 11'th Mar 2023 The Motley Fool
Going with these great dividend stocks is an easy choice.
The Near-Perfect Portfolio: Sleep Well During Turbulent Times
09:00am, Saturday, 11'th Mar 2023
The stock market is inherently volatile. With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. For most conservative investor
Dividend Stock Watch List: Lanny's March 2023 Edition
06:22am, Saturday, 11'th Mar 2023
Dividend investing happens, whether the stock market is up or down, whether the Fed raises interest rates or lowers. It's all about buying dividend income-producing stocks – the best source of passi
The 4 Dividend Aristocrat Buys For March
03:36pm, Friday, 10'th Mar 2023
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." --Kiplinger.com/Investing. 67 Aristocrats screened as of March 8, 2023, repre
If You Like Johnson & Johnson, You'll Love These Higher-Yielding SWANs
12:30pm, Friday, 10'th Mar 2023 Seeking Alpha
Johnson & Johnson's business model is as defensive as they come. Click here to read on two superior low-volatility SWAN alternatives to JNJ stock.
Should You Invest in the Vanguard Health Care ETF (VHT)?
11:20am, Friday, 10'th Mar 2023 Zacks Investment Research
Sector ETF report for VHT
Johnson & Johnson Layoffs 2023: What to Know About the Latest JNJ Job Cuts
10:59am, Friday, 10'th Mar 2023
Johnson & Johnson (NYSE: JNJ ) layoffs are on the way as the medical, pharmaceutical, and consumer goods company cuts jobs. These layoffs have Johnson & Johnson cutting 350 jobs at its Auris Health an
Zacks Industry Outlook Highlights J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi
09:38am, Friday, 10'th Mar 2023 Zacks Investment Research
J&J, Novo Nordisk, AstraZeneca, Novartis and Sanofi have been highlighted in this Industry Outlook article.
If You Like Johnson & Johnson, You'll Love These Higher-Yielding SWANs
07:30am, Friday, 10'th Mar 2023
Recession is coming and with it plenty of scary headlines about crashing stock prices and financial doom. Low volatility dividend SWANs (sleep-well-at-night) blue chips like JNJ are a great way to rid
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
02:10pm, Thursday, 09'th Mar 2023 The Motley Fool
Income stocks can supercharge your portfolio's growth in a wide range of market environments.
5 Large Drug Stocks to Watch as Sector Picks Up in 2023
01:00pm, Thursday, 09'th Mar 2023 Zacks Investment Research
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sa
5 Large Drug Stocks to Watch as Sector Picks Up in 2023
09:11am, Thursday, 09'th Mar 2023
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sa
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
09:10am, Thursday, 09'th Mar 2023
Innovative Industrial Properties is still witnessing high rent collection rates and just recorded another year of stunning profits. Johnson & Johnson is preparing for some big changes later this year,
10 Best Consumer Staples ETFs
07:01am, Thursday, 09'th Mar 2023
A consumer staple ETF (exchange-traded fund) is an investment fund that tracks a series of stocks in companies that produce essential goods and services. The definition of a "consumer staple" usually
Sign In
Buy JNJ